|
African Journal of Biomedical Research
Ibadan Biomedical Communications Group
ISSN: 1119-5096
Vol. 9, Num. 1, 2006, pp. 37-43
|
African Journal of Biomedical Research, Vol. 9, Vol. 1, 2006, pp. 37-43
Full Length Research Article
Seasonal Variations in antibody response to a Plasmodium
falciparum recombinant circumsporozoite antigen in two villages in South Western
Nigeria.
1Ozurumba, L.N; 1Anumudu,
C.I.; *1Nwagwu, M.N.
¹Cellular Parasitology Programme, Department of Zoology, University of Ibadan,
Nigeria.
*Author for Correspondence: 02-8101430; Fax (02) 8103118,
8103043; e-mail-nwagwu@skannet.com
Received: June,
2005
Accepted in final form: November,
2005
Code Number: md06006
Abstract
An Enzyme Linked Immunosorbent Assay
(ELISA), employing a recombinant peptide capture antigen (R32tet32) was used to
detect antibodies against the circumsporozoite protein (CSP) of the malaria
parasite, Plasmodium falciparum in 169 serum samples from 16 subjects
from two villages, Afefu (FA) and Tobalogbo (TB), in Igbo-Ora Community of Oyo
State, over a period of 12 months. The maximum and mean Ab response for FA was
higher than for TB samples (0.511 AU±0.170, 0.124±0.045U and 0.250±0.070 AU, 0.090±0.019AU
respectively), with the
mean Ab being significantly different (t=2.313; P>0.05). Despite both
villages (FA and TB) falling within the same rainfall data zone, the Ab
response profile for FA showed a positive (seasonal) relationship with rainfall
(r=+0.31, P>0.05) while that of TB was negatively correlated (r=-0.32;
P>0.05). Habits and the environment could be prime contributing factors
alongside the less controllable immunogenetic factors. Data obtained here would
serve as baseline and we suggest other expanded sample size studies to include
data on temperature and other climatic factors to help establish
sub-populations at risk and better empower malariologists in planning and
execution of control programmes.
Key Words: Antibodies, Enzyme Linked Immunosorbent Assay (ELISA),
Circumsporozoite Protein,, Antigen
INTRODUCTION
Parasites of the genus Plasmodium places a huge burden on
human life as a result of the malaria disease they cause. It remains a threat
to almost 50% of the worlds population with 200 million estimated new cases
and 1-2 million deaths per year (Snow et. al., 1998). Individuals in all
continents are potentially at risk, but the greatest deficiency falls on people
in the tropics.
Malaria is initiated with the inoculation of sporozoites
from infected female anopheles mosquitoes. These sporozoites have a short life
span and are highly immunogenic (Tapcharsri et al., 1983; Nussenzweig et al.,
1985). CSP is a major surface antigen which uniformly surrounds the external
coat of the malaria sporozoite (Cochrane et al, 1980; the circumsporozoite
tetrapeptide present their-in was derived from an open reading frame in the
tetracydine resistant region (TCR) of E.coli expression plasmid (Webster
et al.., 1987).
Elaborate seroepidemiological studies have been made
possible by ELISAs. They help in the definining and collaboration of baseline
data on the development of natural immunity to malaria in remote locations.
Thus helping in monitoring progress made in malaria control programmers
(Tapchaisri et al, 1985).
The seasonality of malaria has been recorded by the
likes of Webster et al (1988) and Babiker et. al., (1998). In a study, Lindsay
and Birley (1996) stated that the transmission of P.falciparum depends
upon the survival, abundance and infectious periods of the malaria while the
vector rely upon suitable climatic conditions. Snow et al.(1998) on the other
a hand showed in their work that areas with low rainfall limits the
transmission potential while the areas with low temperature reduce the duration
of both the sporogonic and gonotrophic cycles; thus limiting the chances of
parasite transmission. Classical works by Esposito et al (1988) and Druilhe et
al (1986) indicated a substantial seasonal variation in the levels of
antibodies to the synthetic recombinant antigens, even in adults living in
areas of extreme high malaria transmission.
Climate-based models are being developed to identify
and monitor geographical areas that are most at risk from malaria epidemics.
The models predict risk of malaria transmission on the basis of rainfall and
temperature and validation of the results generated from the model using
historical malaria data, have shown that such models provide a good estimation
of spatial risk (WHO/TDR, 2004). Of global deaths attributed to malaria, 90%
now occur in sub-saharan Africa. Recent advances in public health
are offering new opportunities to make significant reductions in burden of
disease (MARA/ARMA, 2001); and malaria risk mapping, offers such a service
which can help to better support planning and programming of malaria control.
Though seasonality of malaria transmission pattern has been reported in
previous studies, as highlighted above, in this paper, we attempt opening up
the variability in patterns of falciparum malaria Ab responses and the
potential positive complimentary, role of malaria risk mapping in control.
The objectives of this paper include the determination
of the individual and mean levels of Ab response to the CSP (R32tet32)
construct. Also, the relationship of Ab response to rainfall in each of the
villages were compared. The work will also bring to light, the role of ELISA
and potential role of spatial risk mapping in the control of malaria.
MATERIALS AND METHOD
Study site: The two villages Afefu and Tobalogbo are located in
Igbo-Ora community in the Ifeloju Local Government areas of OyoState.
Subjects: They were participants in a longitudinal epidemiological
study carried out by the Cellular Parasitology Programme research team. 169
serum samples including 2 controls were used for the study. Samples were
collected fortnightly.
Approximately 500ul of blood was obtained by finger
pricking from each subject and transferred into anti-coagulant containing
micro-test tubes. The blood samples were transported to Ibadan on ice packs. These were later
brought into the laboratory after 2-6 hours and stored at 4ºC for 24-48hours.
The samples were centrifuged at 10,000rpm for 5minutes at 4ºC. The sera
subsequently obtained were stored in small aliquots at -70ºC in the
laboratory. They were later stored at 4°C, enable the samples to
thaw before running assays on them.
Cahorts were discouraged from taking anti-malarial
agents such as Agbo prepared from the neem tree, Azadirachta indica
before entering the survey. They were supplied with drugs and treated for various
ailments at the Centre for Preventive and Social Medicine of the Ibadan
University College Hospital (UCH) in Igbo-Ora. Subjects were indegenes of the
community. They live in the farm during the weekdays and move to town at
weekends.
ELISA method: A total of 169 serum samples were tested by
an enzyme-linked immunosorbent assay (ELISA) using R32tet32 as capture antigen
in 8 microtitre plates. On the first day, the stock capture antigen was
diluted at a concentration of 1:2,000 with solution A (Boiled casein and
phosphate buffered saline at a dilution of 4:5,000) 50ul was evenly dispensed
into each of the wells (nos. 2-11) of the 8 microtitre plates using
multichannel pipettor. These plates were covered and incubated overnight at 4 °C.
This was followed by aspiration of well contents using a multichannel
pipettor. Each of the wells were then filled with 200ml blocking buffer and
left for 1hour at laboratory temperature. The 169 test human sera samples were
diluted 1:200 in blocking buffer in small tubes including the control positive
and negative sera. Then, 50ul of this solution was dispensed in duplicates (to
ensure follow-up re-runs, for reproducibility) into each of the wells 3 to 11
and the plates covered. After a-2 hour incubation at room temperature, the
well contents were aspirated, the plates washed twice with 0.5% (v/v) PBS-Tween
20 wash solution. The 1st and 12th rows, and the
peripheral wells had no sera samples (blanks). The plates were then blotted
and 50ul of peroxidase conjugated mouse anti-human immunoglobin G (IgG)
solution diluted 1:5000 in blocking buffer was added to each well. The plates
were allowed to stand at laboratory temperature for 1 hour, the plates were
aspirated and washed twice with the PBS-Tween 20 wash solution. 50ul of ABTS
substrate was added to each well covered and incubated in the dark for 1 hour.
Then, 50ul of 1% SDS solution was added into each well to stop the reaction.
The absorbance values at wavelenth of 405nmwas determined using a Vmax kinetic
microplate reader (Responders: mean ELISA absorbance value >0.09AU)
The absorbance values of the blanks for each column
were subtracted from the absorbance values for the wells containing R32tet32.
The mean values and the standard deviation (SD) was then calculated. The format
used permitted sera from 2 subjects to be assayed per plate for the 13 months
duration. Samples were not obtained for few of the months for some subjects.
Hence the base line insight of the data.
The positive control sera came from an individual who
was shown to be making anti-circumsporozoite antibodies while the negative
control sera came from an individual who was not shown to be making
anti-circumsporozoite antibodies in a longitudinal study on natural immunity
to
malaria in a falciparum malaria endemic area (Igbo-Ora).
Statistical analysis was done using mean values, SD,
student `t test and the person product moment correlation coefficient.
RESULTS
The maximum mean absorbance values were obtained in the
months of August (0.202±0.160AU) for FA samples and in the months of April,
1993 (0.143±0.084AU) for TB samples. (Tables 1 & 2). Table shows the
monthly mean absorbance values of FA samples (mean monthly rainfall data
included)
Table 1:The monthly mean absorbance values of FA samples (mean
monthly rainfall data included)
MTH
|
Rainfall (mm)
|
FA 02
|
FA 05
|
FA 07
|
FA 012
|
FA 14
|
FA28
|
FA29
|
FA31
|
Mean
|
April 1
|
150
|
0.165 ±0.0269
|
0.1445 ±0.0275
|
0.046 ± 0.0057
|
0.1930 ±0.0410
|
0.1625 ±0.0361
|
-
|
-
|
-
|
0.142
|
May
|
155
|
0.0515 ±0.0064
|
-
|
0.044 ±0.0055
|
-
|
-
|
0.0395 ±0.0347
|
-
|
-
|
0.045
|
June
|
210
|
0.3375 ±0.2112
|
-
|
-
|
0.2110 ±0.0085
|
0.0070±0.0141
|
0.0545 ±0.0007
|
0.0515 ±0.0177
|
0.0860 ±0.0170
|
0.135
|
July
|
175
|
0.3815 ±0.1096
|
0.0775 ±0.0191
|
0.0230 ±0.0127
|
0.5105 ±0.1732
|
0.1190 ±0.0042
|
0.1790 ±0.0057
|
0.0345 ±0.0021
|
0.0095 ±0.0035
|
0.167
|
Aug
|
125
|
0.4425 ±0.1153
|
-
|
0.0530 ±0.0339
|
0.2750 ±0.0424
|
0.1580 ±0.0255
|
0.0825 ±0.0078
|
-
|
-
|
0.202
|
Sept
|
175
|
-
|
0.0850 ±0.0255
|
0.0070 ±0.0028
|
0.2060 ±0.0226
|
-
|
0.2460±0.0028
|
0.0265 ±0.0106
|
0.0040 ±0.0014
|
0.096
|
Oct
|
180
|
0.3735 ±0.0050
|
0.0675 ±0.0035
|
0.0320 ±0.0028
|
0.4730 ±0.0396
|
0.0710 ±0.0042
|
0.1115 ±0.0101
|
-
|
0.0750 ±0.017
|
0.172
|
Nov
|
60
|
0.3980 ±0.0552
|
0.1385 ±0.0035
|
0.0615 ±0.0092
|
0.3200 ±0.0424
|
0.1635 ±0.0431
|
0.1365 ±0.0262
|
-
|
0.0190 ±0.0042
|
0.176
|
Dec
|
20
|
0.2195 ±0.0361
|
0.0255 ±0.0035
|
0.0360 ±0.0212
|
0.2055 ±0.0304
|
0.1050 ±0.0184
|
0.1635 ±0.0233
|
-
|
0.0080 ±0.0014
|
0.109
|
Jan
|
5
|
0.2955 ±0.0884
|
0.0730 ±0.0269
|
0.0365 ±0.0205
|
0.2520 ±0.0410
|
0.0685 ±0.0021
|
0.0845 ±0.0290
|
0.0100 ± 0.6099
|
0.0050 ±0.0014
|
0.103
|
Feb
|
50
|
0.1515 ±0.0149
|
-
|
0. 0375 ±0.0092
|
0.1650 ±0.0071
|
0.0640 ±0.0113
|
0.0610 ±0.0028
|
0.0300 ±0.0057
|
-
|
0.073
|
Mar
|
100
|
0.1370 ±0.0948
|
0.0250 ±0.028
|
0.0215 ±0.0050
|
0.1705 ±0.0050
|
-
|
0.0875 ±0.0474
|
0.0375 ±0.0149
|
-
|
0.080
|
April 2
|
150
|
0.3470 ±0.1104
|
0.1375 ±0.0799
|
0.1145 ±0.0219
|
0.2740 ±0.0877
|
-
|
0.1740 ±0.0707
|
0.0700 ±0.0028
|
0.0230 ±0.0113
|
0.163
|
Absorbance in absorbance units (AU); R= + 0.31 ; P>0.05
; df = 11
Table 2: The monthly mean absorbance values of TB samples
Month
|
TB 01
|
TB 02
|
TB03
|
TB04
|
TB 05
|
TB 06
|
TB 07
|
TB 08
|
MEAN
|
(t) VALUE
|
April 1
|
0.0540 ±0.0156
|
0.0625 ±0.0078
|
0.1460 ±0.0396
|
0.0455 ±0.0191
|
0.1460 ±0.0792
|
0.0630 ±0.0170
|
0.0365 ±0.0035
|
0.0400 ±0.0255
|
0.074
|
2.620
|
May
|
-
|
0.0345 ±0.0007
|
0.0395 ±0.0205
|
-
|
0.212 ±0.024
|
0.0320 ±0.0156
|
-
|
0.0050 ±0.0028
|
0.065
|
0.013
|
June
|
0.0370 ±0.001
|
0.0280 ±0.0071
|
0.0970 ±0.0028
|
0.0275 ±0.0134
|
0.1530 ±0.0693
|
0.1715 ±0.0007
|
-
|
-
|
0.085
|
0.902
|
July
|
-
|
0.0325 ±0.0078
|
0.1135 ±0.0431
|
0.0315 ±0.0106
|
0.1680 ±0.0297
|
0.0635 ±0.0007
|
0.0150 ±0.0028
|
0.1020 ±0.0240
|
0.075
|
0.253
|
Aug
|
0.0335 ±0.0064
|
0.0595 ±0.0163
|
0.0590 ±0.0113
|
0.0310 ±0.0226
|
0.2645 ±0.0686
|
0.0680 ±0.0368
|
0.0110 ±0.0014
|
0.0950 ±0.0325
|
0.078
|
0.276
|
Sep
|
0.0230 ±0.0042
|
0.0540 ±0.0071
|
0.1140 ±0.0240
|
0.0190 ±0.0057
|
0.2020 ±0.0014
|
0.1630 ±0.0354
|
0.0150 ±0.0042
|
0.0985 ±0.0745
|
0.084
|
0.240
|
Oct
|
0.0335 ±0.012
|
-
|
0.0710 ±0.002
|
0.0060 ±0.0042
|
0.1175 ±0.0050
|
0.1665 ±0.0488
|
0.080 ±0.0071
|
0.1210 ±0.0085
|
0.065
|
1.512
|
Nov
|
0.1490 ±0.0212
|
0.0810 ±0.0113
|
0.1050 ±0.0014
|
0.0165 ±0.0007
|
0.2330 ±0.0297
|
-
|
0.1380±0.0679
|
0.1320 ±0.024
|
0.122
|
0.253
|
Dec
|
0.0270 ±0.0155
|
0.0490 ±0.0014
|
0.1320 ±0.0014
|
0.0170 ±0.0042
|
0.1760 ± 0.0042
|
0.1415 ±0.0644
|
0.0220 ±0.0028
|
0.1175 ±0.0191
|
0.087
|
0.512
|
Jan
|
0.0570 ±0.0014
|
0.0410 ±0.0099
|
0.0730 ±0.0608
|
0.0375 ±0.0064
|
0.1930 ±0.0071
|
0.0865 ±0.0078
|
-
|
0.1880 ±0.0014
|
0.097
|
0.170
|
Feb
|
0.0790 ±0.0269
|
0.0535 ±0.0134
|
0.1725 ±0.0078
|
0.0300 ±0.0042
|
0.1415 ±0.1054
|
0.1425 ±0.0084
|
-
|
0.0840 ±0.0240
|
0.101
|
0.230
|
Mar
|
-
|
0.0290 ±0.0014
|
0.1115 ±0.0177
|
0.0870 ±0.0283
|
0.2130 ±0.0028
|
0.1585 ±0.0347
|
-
|
-
|
0.120
|
0.672
|
April 2
|
0.0285 ±0.0035
|
-
|
0.1685 ±0.0219
|
0.0575 ± 0.0191
|
0.2550 ±0.0679
|
0.1600 ±0.0948
|
-
|
0.1855 ±0.0545
|
0.143
|
0.690
|
t t test (*significantly different) between mean of FA and
TB absorbance values)
April12 = 1st and following year
(1991& 1992); R = -0.32 ; df =
Table 2: The monthly mean absorbance values of TB samples
Table 3: Summary of result and cases of malaria recorded. (Confirmed from clinic
health records)
The month of may recorded the minimum antibody titre for
both FA and TB samples (0.045±0.006AU and 0.065±0.083AU respectively). A
statistical comparison using the one-tailed students t-test showed no
significant difference between these two values (t=0.0133; P>0.05; df=6).
The mean absorbances showed a significant difference only in the month of
April, 1992 (t=2.62 ; P>0.05; df=11) (table 1).
The person correlation coefficient analysis of the
mean absorbance of FA with TB samples showed a negative correlation (r = -
0.0041; P>0.05; df=11).
Correlation of Rainfall distribution with mean absorbencies:
The amount of
rainfall peaked in the month of June with the least being recorded in January
(Figs 1 & 2). There was a positive correlation between mean absorbance and
rainfall distribution for the various months for FA samples (r = +0.31;
P>0.05, df=11) while that for TB samples showed a negative correlation (r =
-0.3.2); P >0.05; df = 11). (Tables 1& 2 ).
DISCUSSION AND CONCLUSION
A considerably high number of the subjects produced
antibodies that were reactive with the circumsporozoite recombinant peptide,
R32tet32 (7 from each village amounting to 14 out of 16 -87.5% from both
villages). The level of antibody response was not dependent on the number of
clinical malaria infection .
This remark is consistent with the stage and species
specificity of the immune response. Thus, the Ab response profile measured
could serve as a useful indicator of the level of malaria transmission.
Druihle et al (1986) and Esposito et al (1988) equally corroborated this
conclusion.
Table 3:Summary of result and cases of malaria recorded. (Confirmed
from clinic health records).
Subject
|
Anti-CSP antibody Response
|
Cases of Malaria
|
FA02
|
+
|
Nil
|
FA05
|
+
|
X
|
FA07
|
+
|
X, *,
|
FA12
|
+
|
CQ
|
FA14
|
+
|
CQ
|
FA28
|
+
|
X,
|
FA29
|
-
|
◊
|
FA31
|
+
|
Nil
|
TB01
|
+
|
Nil
|
TB02
|
-
|
X, #,
|
TB03
|
+
|
Nil
|
TB04
|
+
|
X
|
TB05
|
+
|
◊
|
TB06
|
+
|
#,
|
TB07
|
+
|
X,#
|
TB08
|
+
|
◊
|
X: Positive
smear; malaria suspected within 1st 3rdmonths and treated
#: Positive
smear; malaria suspected between 3rd and 7th month and
treated
*: Positive
smear; malaria suspected between 7th and 10th month and
treated
◊: Positive
smear; malaria suspected between 7th and 10th month and
treated.
CQ: Treated with
chloroquine
Nil: No case of
malaria.
Except for F29 and TB02 (Tables 1 & 2
respectively) who both responded negatively, all other subjects that recorded
cases of malaria were responders (Table 3) This illustrates the fact that, it
is possible that rising antibody levels was experienced in subjects at the time
a blood stage infection that was sufficient to cause symptoms developed
(Webster et al, 1987). Also, it conforms with the discovery that inoculation
of sporozoites which results in acute P. falciparum infection may or
may not stimulate an antibody response to sporozoite antigens (Brown et al,
1989).
TB08, TB05, TB06, TB07, FA05, FA07, FA14, and
FA28 all recorded peaks after the first case of suspected malaria was
treated and suggests that the first episode of malaria may have been
only partially treated while the second case was probably just a
recrudescence. Occasionally, after treatment, there were instances in which Ab
titres failed to show a significant rise during subsequent episodes (FA31,
TB01, TB04 and TB07). There were also instances in which the periods of
positive Ab response failed to correspond with the periods in which subjects
were treated such as in FA29 and TB02 which were non-responders throughout.
The inconsistent nature of some of these highlighted
results, relating Ab responses and recorded cases of malaria (Tables 1,2 &
3) could be as result of variation in T-cell epitope(s) to which the helper
T-lymphocyte were responding (Good et al, 1988), especially when there is an
antigen defect in the T-helper lymphocyte function while the general levels of
Ab responses recorded could have been influenced by the half-life of
immunoglobulin G (IgG) antibodies (Young et al, 1985), and the blood stage
specificity of the circumsporozoite proteins (Dame et al, 1984).
However, some subjects still showed consistencies in
which periods of positive anti-circumsporozoite protein responses corresponded
with the periods in which malaria cases were recorded FA02, FA12, FA14,FA28,
TB05, TB06 and TB08 (Tables 1,2 & 3 ). Responders FA02, FA31, TB01 TB03
that showed no case of malaria during the period of survey also showed
consistencies in results.
Despite the location of the two villages within the
same geographical zone with similar socio-economic settings, varying seasonal
profiles of Ab response was recorded. High levels of Ab response was recorded
between April and October for FA (rainy season period) while it was between
November and April for TB (dry season period).
Furthermore, the antibody response profile for FA
samples showed a positive correlation with rainfall (r=+0.31; P>0.05) while
that of TB samples was negatively correlated (r=-0.32; P>0.05) (Table 1&2
). The trend in FA is similar to that obtained by Webster et al (1988) in
South Western Thailand. This they attributed to a combination of factors
involving human and vector (mosquito) behaviour which determine their exposure
to infection. Examination of this micro variations may reveal other clues useful
for control. Nwagwu et al (1998) reported seasonal relationship from the
outcome of their study in which they dealt more on the immune status of the
subjects, in the adjoining border villages within the same community. Knowledge
of variation in parasite populations, if any, according to dry/low season in a
place is of particular interest in Africa and other endemic areas for national
malaria control programme. (Issifou et al, 2001). Studies on the relief of
the two villages showed that they both have streems that dry up from November
to march and which both fill up in the rainy season (DalyMT, FilaniMO and Richards P, unpublished report). This implies that positive titres
(responses) and indeed episodes of malaria are expected to fall sharply between
November and March, the period in which most of the collected water must have
drained up, as this was the case in only Afefu village. This not withstanding,
both villages still showed significantly high levels of positive titres and it
could be attributed to the rocky nature of both areas which provide suitable
breeding sites for mosquitoes in the villages.
Since parasite, vectorial, environmental, climatic and
human (such as habits and immunity status) factors, are some of the major
parameters which greatly influence the epidemiology and level of disease
transmission (Snow et al., 1988; Craig et. al., 1999), it is not unlikely that
the varying response profiles for Afefu and Tobalogbo could be related to the
habits and the climate, of which rainfall (brought into focus in this work),
temperature, humidity and topography are the most important in malaria
epidemiology (Ukoli, 1990). They affect the life cycle and behaviour of the
mosquito vector and the rate of the development of the parasite within it.
Amongst these factors, only rainfall and temperature are used as the basis for
establishing models to predict risk of malaria transmission. These sort of
models have been shown to provide a good estimation of malaria spatial risk
(WHO/TDR, 2004; MARA/ARMA, 2001). It is worth noting that the habits of the
subjects in both villages involve daily and seasonal variation in their
exposure to the risks of infection. The earlier highlighted epidemiological
factors are known to determine mans clothing, housing and general life style
and it would definitely ripple out on the degree of exposure and level of
transmission of the disease. Snow et al., (1998) supports this assertion as
they reported that climate operates to affect the vectorial capacity of P.
falciparum transmission with rainfall acting by limiting transmission
potential, while survival, abundance and infectious periods of malaria vectors
rely upon suitable climatic conditions (Lindsay and Birley, 1996). With the
launching of Nigeria sat-1 by the National Space
Research and Development Agency (NASRDA) of Nigeria in September, 2003, its potential for detailed climatic data supplies
can be exploited in epidemiological surveys involving malaria and other
infections diseases. This should alongside, data obtained from parasitological
and georeferencing work, help in spatial modeling of malaria distribution
patterns and establish sub-populations at risk (MARA/ARMA, 2001; WHO/TDR,
2004). This approach has proved particularly useful in countries like China where only one province (Yunnan) remains with a significant
transmission level of Plasmodium falciparum (TDR News 70 , 2003).
What then is the role of the ELISA employed in malaria
epidemiology one might ask? The answer is simple. Despite its possible sources
of human and technical error Wirtz et. al. (1998), which is of minimal
significance, it still serves as a useful indicator of sporozoite parasite
inoculation, thereby shedding more light on the natural history of
host-parasite relationship and in sero-epidemiological surveys, whose use in
control programmes has shown promise, irrespective of the odds.
These corroborative findings (despite the sample size)
suggests firmer approach to the management of human (habits) and environmental
factors by those living in endemic areas, such as in the areas under study, especially
when these factors are more controllable than the innate features. Coupling
these to malaria risk mapping would greatly support planning and implementation
of our control programmes. Future expanded sample-size studies is advocated for
further insight, as this presented data will serve as a baseline.
ACKNOWLEDGEMENT
-
This work was
party financed and supported by the Research Strengthening Group of the
UNDP/World Bank/WHO Special Programme for Research and Training in Tropical
Diseases through a grant awarded to Professor M. Nwagwu (Rtd).
-
We appreciate
the kind cooperation of the two villages in Igbo-Ora community and members
of the programmes field team.
-
We thank Dr.
R. A. Wirtz of Walter Reed Army Institute of Medical Research, Washington
D.C., USA, for his gift of the recombinant capture antigen - R32tet32 used
for the
ELISA.
-
Huge thanks
also to medical and non-medical personnel of the College of Medicine, University
of Ibadan, attached to the Igbo-Ora Community Health programme for technical
assistance and use of their facilities.
-
Babiker H.A., Abdel Mushin A.M., Ranford Cartwright L.C., Satti G., Walliker D.
(1998).
Characteristics of Plasmodium falciparum parasites that survive
the lengthy dry season in Eastern Sudan where malaria transmission is markedly
seasonal., Am J Trop Med and Hyg 59 (4): 582-90.
-
Brown A.E., Webster H.K., Pavanand K., Barnyen P., Sookto
J.S. and Gingrich J.B. (1989). Comparison of antibody responses to
the circumsporozoite protein repeat region and to intact sporozoites during
acute falciparum
malaria. Trans R Soc Trop Med and Hyg; 154-157.
-
Cochrane A.H., Nussenzweig R.S. and Nardin E.H. (1980). Immunization
against sporozoites.
J.P Kreier ed. New YorkAcademy Press, Malaria; 3:163-202.
-
Craig M.H, Snow R.W. and Le Sueur D.A. (1999). Climate-based
distribution model of malaria transmission in Africa. Parasitology Today;
15: 105-111.
-
Dame J.B., Williams J..L., McCutchan T.F., Weber J.L., Wirtz
R.A., Hockmeyer W.R., Maloy W.L., Haynes J.D., Scheneider I., Roberts D.,
Sanders G.S., Reddy E.P., Diggs C.L. and Miller L.H. (1984) Structure
of the gene encoding the immunodominant surface antigen on the sporozoite
of the human malaria parasite, Plasmodium falciparum. Science;
225: 593 - 599.
-
Druilhe P., Pradier P.O., Marc J.P., Miltgen F., Mazier D.
and Parent G. (1986) .Levels of antibodies to plasmodium falciparum
sporozoite surface antigens reflect malaria transmission rates and are
present in the absence of
reinfection. Infect Immune; 53:393-397.
-
Durrheim D.N., Govere J., La Grange
J.J.P., Mabuza A. (2001) Rapid immunochromatographic diagnosis and
Rolling Back malaria-experiences from an African control programme. Afr
J Med Sci; 30,Suppl. 21-24.
-
Esposito F., Lombardi S., Modiano D.,
Zavala F., Reeme J., Lamizana L., Coluzzi M. and Nussenzweig R.S. (1988).Prevalence and levels of antibodies
to the circumsprozoite protein of Plasmodium falciparum in an endemic
area and their relationship to resistance against malaria infection. Trans
R Soc Trop Med and Hyg; 82:827-832.
-
Good M.F., Berzofsky J.A. and Miller L.H. (1988). The T-cell
response to malaria circumsporozoite protein and immunological approach
to vaccine development. Ann Rev Immunol.; 6: 663-688.
-
Issifou S., Ndjikou S., Sanni A., Lekoulou F., Ntoumi F. (2001). No influence of the transmission
season on genetic diversity and complexity of infections in Plasmodium
falciparum isolates from Benin, Afr J
Med Sci; 30, suppl.17-20.
-
Lindsay SW and Birley MH. Climate change and malaria
transmission. (1997)
Annals of Tropical Medicine and Parasitology; 90:573-588.
-
MARA/ARMA. (1998). Towards on Atlas of malaria Risk in Africa. First
Technical Report of the MARA/ARMA Collaboration 1998, Durban.
-
Nussenzweig V. and Nussenzweig R.S. (1985). Circumsporozoite proteins of malaria
parasites. Cell; 42: 401-403
-
Nwagwu M., Anumudu C.A., Sodeinde O., Ologunde C.A., Obi
T.U, Wirtz R.A., Gordon D.M. and Lyon J.A. (1998). Identification of a subpopulation of
immune Nigerian Adult Volunteers by antibodies to the circumsporozoite protein
of Plasmodium falciparum. Am J Trop Med Hyg; 58(5): 684-692.
-
Snow R.W., Gows E., Omumbo J., Rapuoda B., Craig M.H.,
Transer F.C., Le Sueur D. and Ouma J. (1998). Model to predict the intensity of Plasmodium
falciparum transmission: applications to the burden of the disease
in Kenya. Trans R Sec Trop Med Hyg; 92: 601-606.
-
Tapchaisri P.A., Asavanich S., Limsuwan S., Tharavanji S.
and Harinasuta T. (1985). Antibodies against malaria sporozoites in patients with acute
uncomplicated malaria and patients with cerebral malaria. Am J Trop Med
Hyg; 34:831-836.
-
Tapchaisri P.A., Chomcharm C.P. Asavanich A., Limsuman S.,
Maleevan O., Tharvanj S. and Harinasuta T. (1983). Anti-sporozoite
antibodies indusced by natural infection. Am J Trop Med Hyg; 32: 1203-1208.
-
TDR News. (1983) A UNDP/World Bank/WHO Publication ; 70 , Oct:
15.
-
TDR (1993) Report of the Steering Committee of the Scientific
Working Group on Epidemiology. July 1978 June 1983; Document TDR/EPI/SC-SWG
(78-83)/83.3.
-
Ukoli F.M.A. (1990). Introduction to Parasitology in Tropical Africa ; Textflow
Ltd. Ibadan.
-
Van der Hoek W , Konradsen F., Dijkstra D.S., Amerisinghe
P.H., Amerasinghe F.P. (1998). Risk factors for malaria: a microepidemiological
study in a village in Sri Lanka. Trans R Soc Trop Med Hyg; 92 (3):
265-9.
-
Webster H.K., Boudreau E.F., Pang L.W., Permpanich B.,
Sookto P. and Wirtz R.A. (1987). Development of Immunity in Natural Plasmodium falciparum
Malaria: Antibodies to the falciparum sporozoite vaccine / antigen
(R32tet32). J. Cli Microbiol.; .25. (6): 1002-1008.
-
Webster H.K., Brown A.E., Chuenchitra C., Permpanich B. and
Pipithkul J. (1988) .Characterization of antibodies to sporozoites
in plasmodium falciparum malaria and correction with protection. J Cli Microbial; 2:
923-927.
-
WHO/TDR (2004) Predicting Malaria Epidemics in Africa. 1997-98
Malaria / AFR-Progress report.
-
Wirtz R.A., Duncan J.F., Njelesani E.K., Schneider I., Brown A.E., Oster C.N., Were J.B.,
Webster H.K. (1989).
ELISA method for detecting Plasmodium falciparum circumsporozoite
antibody. Bull World Health Organ; 67: 535-542.
-
Young J.F., Hockmeye W.T., Gross M., Ballou W.P., Wirtz
R.A., Trosper J.H., Beaudoin R.L., Hollingdale M.R., Miller LH, Diggs C.L. and
Rosenberg M. (1985).
Expression of Plasmodium falciparum circumsporozoite proteins in E.coli
for potential use in a malaria vaccine. Science; 288: 958-962.
© Ibadan Biomedical Communications Group
|